Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | ACP1 | P24666 | 2/20 | 0.48 |
| ▸ | FDPS | P14324 | 1/20 | 0.47 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.46 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | EDNRA | P25101 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | NOS1 | P29475 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL28371825 | 0.86 | ALDH1A1 (0.46) | ALDH1A1TDP1ACP1PLA2G7GRM4 | |
| SCHEMBL2546678 | 0.83 | GRM4 (0.47) | ALDH1A1TDP1ACP1FDPSPLA2G7 | |
| SCHEMBL14048344 | 0.79 | ALDH1A1 (0.45) | ALDH1A1TDP1ACP1FDPSPLA2G7 | |
| SCHEMBL8629253 | 0.79 | ALDH1A1 (0.38) | ALDH1A1TDP1ACP1FDPSPLA2G7 | |
| SCHEMBL722560 | 0.79 | RAB9A (0.59) | ALDH1A1TDP1PLA2G7LMNASMN1; SMN2 | |
| SCHEMBL17397927 | 0.79 | PLA2G7 (0.49) | ALDH1A1TDP1PLA2G7GRM4LMNA | |
| SCHEMBL14281292 | 0.78 | — | — | |
| SCHEMBL2807100 | 0.78 | — | — | |
| SCHEMBL13879142 | 0.78 | — | — | |
| SCHEMBL454310 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7858724-B2 | Polymeric, phosphorescent, organically semi-conductive emitter materials based on perarylated boranes, method for their production and use thereof | OSRAM OPTO SEMICONDUCTORS GMBH (DE) | 2010-12-28 | — | — | US | claimed |
| EP-1699898-B1 | POLYMERIC, PHOSPHORESCENT, ORGANICALLY SEMI-CONDUCTIVE EMITTER MATERIALS BASED ON PERARYLATED BORANES, METHOD FOR THEIR PRODUCTION AND USE THEREOF | OSRAM OPTO SEMICONDUCTORS GMBH (DE) | 2008-10-29 | — | — | EP | claimed |
| US-20070191587-A1 | Polymeric, phosphorescent, organically semi-conductive emitter materials based on perarylated boranes, method for their production and use thereof | OSRAM OLED GMBH (DE) | 2007-08-16 | — | — | US | claimed |
| CN-113200939-A | Bis (1, 3-thiazole) amine and preparation method thereof | 广东石油化工学院 | 2021-08-03 | — | — | CN | disclosed |
| CN-113200939-A | Bis (1, 3-thiazole) amine and preparation method thereof | 广东石油化工学院 | 2021-08-03 | — | — | CN | disclosed |
| US-20110288136-A1 | FLAVIVIRUS INHIBITION BY SULTAMS AND RELATED COMPOUNDS | OREGON HEALTH & SCIENCE UNIVERSITY | 2011-11-24 | — | — | US | disclosed |
| US-8003674-B2 | Flavivirus inhibition by sultams and related compounds | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2011-08-23 | — | — | US | disclosed |
| US-7858724-B2 | Polymeric, phosphorescent, organically semi-conductive emitter materials based on perarylated boranes, method for their production and use thereof | OSRAM OPTO SEMICONDUCTORS GMBH (DE) | 2010-12-28 | — | — | US | disclosed |
| US-20100234434-A1 | FLAVIVIRUS INHIBITION BY SULTAMS AND RELATED COMPOUNDS | OREGON HEALTH & SCIENCE UNIVERSITY | 2010-09-16 | — | — | US | disclosed |
| EP-1994491-A2 | FLAVIVIRUS INHIBITION BY SULTAMS AND RELATED COMPOUNDS | Oregon Health and Science University (US) | 2008-11-26 | — | — | EP | disclosed |
| WO-2007109105-A2 | FLAVIVIRUS INHIBITION BY SULTAMS AND RELATED COMPOUNDS | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2007-09-27 | — | — | WO | disclosed |
| US-20070191587-A1 | Polymeric, phosphorescent, organically semi-conductive emitter materials based on perarylated boranes, method for their production and use thereof | OSRAM OLED GMBH (DE) | 2007-08-16 | — | — | US | disclosed |
| US-20070184232-A1 | Optical recording materials having high storage density | CIBA SPECIALTY CHEMICALS CORP. | 2007-08-09 | — | — | US | disclosed |
| EP-1719126-A1 | OPTICAL RECORDING MATERIALS HAVING HIGH STORAGE DENSITY | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) | 2006-11-08 | — | — | EP | disclosed |
| WO-2005081239-A1 | OPTICAL RECORDING MATERIALS HAVING HIGH STORAGE DENSITY | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288136-A1 | FLAVIVIRUS INHIBITION BY SULTAMS AND RELATED COMPOUNDS | SHMT1, SULT2A1, GNMT | ALDH1A1 1585/4885TDP1 2703/4885ACP1 4045/4885 |
| US-20100234434-A1 | FLAVIVIRUS INHIBITION BY SULTAMS AND RELATED COMPOUNDS | SHMT1, SULT2A1, GNMT | ALDH1A1 1585/4885TDP1 2703/4885ACP1 4045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.